TreeWAS – Variant ID: rs2706347

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
J45.9 Asthma, unspecified	1.000	0.000	0.000
J45 Asthma	0.892	0.108	0.000
J45.0 Predominantly allergic asthma	0.867	0.133	0.000
J45.1 Nonallergic asthma	0.661	0.339	0.000
J45.8 Mixed asthma	0.639	0.361	0.000
C18.9 Colon, unspecified	0.000	0.958	0.042
C18 Malignant neoplasm of colon	0.000	0.974	0.026
C18.3 Hepatic flexure	0.000	0.976	0.024
C18.2 Ascending colon	0.000	0.979	0.021
C18.8 Overlapping lesion of colon	0.000	0.979	0.021
C18.5 Splenic flexure	0.000	0.979	0.020
C18.6 Descending colon	0.000	0.981	0.019
C18.7 Sigmoid colon	0.000	0.983	0.017
C18.1 Appendix	0.000	0.984	0.016
J40-J47 Chronic lower respiratory diseases	0.016	0.984	0.000
C18.4 Transverse colon	0.000	0.986	0.014
J42 Unspecified chronic bronchitis	0.012	0.988	0.000
J41 Simple and mucopurulent chronic bronchitis	0.012	0.988	0.000
C18.0 Caecum	0.000	0.989	0.011
J44 Other chronic obstructive pulmonary disease	0.010	0.990	0.000
J44.8 Other specified chronic obstructive pulmonary disease	0.010	0.990	0.000
J41.8 Mixed simple and mucopurulent chronic bronchitis	0.008	0.991	0.000
J41.1 Mucopurulent chronic bronchitis	0.008	0.991	0.000
J41.0 Simple chronic bronchitis	0.008	0.991	0.000
J43 Emphysema	0.008	0.992	0.000
J44.1 Chronic obstructive pulmonary disease with acute exacerbation, unspecified	0.008	0.992	0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.008	0.992	0.000
J46 Status asthmaticus	0.008	0.992	0.000
T36-T50 Poisoning by drugs, medicaments and biological substances	0.008	0.992	0.000
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.007	0.993	0.000
T43.3 Phenothiazine antipsychotics and neuroleptics	0.007	0.993	0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.007	0.993	0.000
T43.5 Other and unspecified antipsychotics and neuroleptics	0.007	0.993	0.000
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.007	0.993	0.000
T46 Poisoning by agents primarily affecting the cardiovascular system	0.007	0.993	0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.007	0.993	0.000
J43.8 Other emphysema	0.007	0.993	0.000
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.007	0.993	0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.007	0.993	0.000
G58.8 Other specified mononeuropathies	0.006	0.994	0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.006	0.994	0.000
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.006	0.994	0.000
J43.1 Panlobular emphysema	0.006	0.994	0.000
J43.0 MacLeod's syndrome	0.006	0.994	0.000
T46.4 Angiotensin-converting-enzyme inhibitors	0.006	0.994	0.000
T43.4 Butyrophenone and thioxanthene neuroleptics	0.006	0.994	0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.006	0.994	0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.006	0.994	0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.006	0.994	0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.006	0.994	0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.006	0.994	0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.006	0.994	0.000
T44.1 Other parasympathomimetics [cholinergics]	0.006	0.994	0.000
T44.0 Anticholinesterase agents	0.006	0.994	0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.006	0.994	0.000
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.006	0.994	0.000
T36 Poisoning by systemic antibiotics	0.006	0.994	0.000
J43.2 Centrilobular emphysema	0.006	0.994	0.000
T41 Poisoning by anaesthetics and therapeutic gases	0.006	0.994	0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.006	0.994	0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.006	0.994	0.000
T39.1 4-Aminophenol derivatives	0.006	0.994	0.000
T43.9 Psychotropic drug, unspecified	0.005	0.994	0.000
T43.8 Other psychotropic drugs, not elsewhere classified	0.005	0.994	0.000
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.005	0.994	0.000
T46.3 Coronary vasodilators, not elsewhere classified	0.005	0.994	0.000
T43.6 Psychostimulants with abuse potential	0.005	0.994	0.000
T40.2 Other opioids	0.005	0.994	0.000
T39.0 Salicylates	0.005	0.995	0.000
T40.6 Other and unspecified narcotics	0.005	0.995	0.000
T46.5 Other antihypertensive drugs, not elsewhere classified	0.005	0.995	0.000
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.005	0.995	0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.005	0.995	0.000
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.005	0.995	0.000
M23.26 Derangement of meniscus due to old tear or injury (Other and unspecified lateral meniscus)	0.000	0.995	0.005
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.005	0.995	0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.005	0.995	0.000
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.005	0.995	0.000
T46.8 Antivaricose drugs, including sclerosing agents	0.005	0.995	0.000
T46.7 Peripheral vasodilators	0.005	0.995	0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.005	0.995	0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.005	0.995	0.000
T50.6 Antidotes and chelating agents, not elsewhere classified	0.005	0.995	0.000
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.005	0.995	0.000
T39.4 Antirheumatics, not elsewhere classified	0.005	0.995	0.000
T39.2 Pyrazolone derivatives	0.005	0.995	0.000
T38.9 Other and unspecified hormone antagonists	0.005	0.995	0.000
T38.8 Other and unspecified hormones and their synthetic substitutes	0.005	0.995	0.000
T38.7 Androgens and anabolic congeners	0.005	0.995	0.000
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.005	0.995	0.000
T38.5 Other oestrogens and progestogens	0.005	0.995	0.000
T38.4 Oral contraceptives	0.005	0.995	0.000
T38.2 Antithyroid drugs	0.005	0.995	0.000
T38.0 Glucocorticoids and synthetic analogues	0.005	0.995	0.000
T46.1 Calcium-channel blockers	0.005	0.995	0.000
T50.4 Drugs affecting uric acid metabolism	0.005	0.995	0.000
T49.9 Topical agent, unspecified	0.005	0.995	0.000
T49.8 Other topical agents	0.005	0.995	0.000
T49.7 Dental drugs, topically applied	0.005	0.995	0.000
T49.6 Otorhinolaryngological drugs and preparations	0.005	0.995	0.000
T49.5 Ophthalmological drugs and preparations	0.005	0.995	0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.005	0.995	0.000
T49.3 Emollients, demulcents and protectants	0.005	0.995	0.000
T49.2 Local astringents and local detergents	0.005	0.995	0.000
T49.1 Antipruritics	0.005	0.995	0.000
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.005	0.995	0.000
T40.8 Lysergide [LSD]	0.005	0.995	0.000
T40.7 Cannabis (derivatives)	0.005	0.995	0.000
T40.5 Cocaine	0.005	0.995	0.000
T40.3 Methadone	0.005	0.995	0.000
T40.1 Heroin	0.005	0.995	0.000
T40.0 Opium	0.005	0.995	0.000
M16.0 Primary coxarthrosis, bilateral	0.005	0.995	0.000
T42.0 Hydantoin derivatives	0.005	0.995	0.000
T48.6 Antiasthmatics, not elsewhere classified	0.005	0.995	0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.005	0.995	0.000
T45.5 Anticoagulants	0.005	0.995	0.000
T45.2 Vitamins, not elsewhere classified	0.005	0.995	0.000
T38.1 Thyroid hormones and substitutes	0.004	0.995	0.000
T36.0 Penicillins	0.004	0.995	0.000
T50.8 Diagnostic agents	0.004	0.995	0.000
T50.7 Analeptics and opioid receptor antagonists	0.004	0.995	0.000
T50.5 Appetite depressants	0.004	0.995	0.000
T50.3 Electrolytic, caloric and water-balance agents	0.004	0.995	0.000
T50.1 Loop [high-ceiling] diuretics	0.004	0.995	0.000
T50.0 Mineralocorticoids and their antagonists	0.004	0.995	0.000
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.004	0.995	0.000
T48.5 Anti-common-cold drugs	0.004	0.995	0.000
T48.4 Expectorants	0.004	0.995	0.000
T48.3 Antitussives	0.004	0.995	0.000
T48.2 Other and unspecified agents primarily acting on muscles	0.004	0.995	0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.004	0.995	0.000
T48.0 Oxytocic drugs	0.004	0.995	0.000
T36.9 Systemic antibiotic, unspecified	0.004	0.995	0.000
T36.8 Other systemic antibiotics	0.004	0.995	0.000
T36.7 Antifungal antibiotics, systemically used	0.004	0.995	0.000
T36.6 Rifamycins	0.004	0.995	0.000
T36.5 Aminoglycosides	0.004	0.995	0.000
T36.4 Tetracyclines	0.004	0.995	0.000
T36.3 Macrolides	0.004	0.995	0.000
T36.2 Chloramphenicol group	0.004	0.995	0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.004	0.995	0.000
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.004	0.996	0.000
T37.8 Other specified systemic anti-infectives and antiparasitics	0.004	0.996	0.000
T37.5 Antiviral drugs	0.004	0.996	0.000
T37.4 Anthelminthics	0.004	0.996	0.000
T37.3 Other antiprotozoal drugs	0.004	0.996	0.000
T37.2 Antimalarials and drugs acting on other blood protozoa	0.004	0.996	0.000
T37.1 Antimycobacterial drugs	0.004	0.996	0.000
T37.0 Sulphonamides	0.004	0.996	0.000
T41.5 Therapeutic gases	0.004	0.996	0.000
T41.4 Anaesthetic, unspecified	0.004	0.996	0.000
T41.3 Local anaesthetics	0.004	0.996	0.000
T41.2 Other and unspecified general anaesthetics	0.004	0.996	0.000
T41.1 Intravenous anaesthetics	0.004	0.996	0.000
T41.0 Inhaled anaesthetics	0.004	0.996	0.000
T45.9 Primarily systemic and haematological agent, unspecified	0.004	0.996	0.000
T45.8 Other primarily systemic and haematological agents	0.004	0.996	0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.004	0.996	0.000
T45.6 Fibrinolysis-affecting drugs	0.004	0.996	0.000
T45.4 Iron and its compounds	0.004	0.996	0.000
T45.3 Enzymes, not elsewhere classified	0.004	0.996	0.000
T43.2 Other and unspecified antidepressants	0.004	0.996	0.000
T47.0 Histamine H(2)-receptor antagonists	0.004	0.996	0.000
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.004	0.996	0.000
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.004	0.996	0.000
T45.0 Antiallergic and antiemetic drugs	0.004	0.996	0.000
J44.9 Chronic obstructive pulmonary disease, unspecified	0.004	0.996	0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.004	0.996	0.000
T47.8 Other agents primarily affecting the gastro-intestinal system	0.004	0.996	0.000
T47.7 Emetics	0.004	0.996	0.000
T47.6 Antidiarrhoeal drugs	0.004	0.996	0.000
T47.5 Digestants	0.004	0.996	0.000
T47.4 Other laxatives	0.004	0.996	0.000
T47.3 Saline and osmotic laxatives	0.004	0.996	0.000
T47.2 Stimulant laxatives	0.004	0.996	0.000
T45.1 Antineoplastic and immunosuppressive drugs	0.004	0.996	0.000
B95.5 Unspecified streptococcus as the cause of diseases classified to other chapters	0.004	0.996	0.000
T42.5 Mixed antiepileptics, not elsewhere classified	0.004	0.996	0.000
T42.3 Barbiturates	0.004	0.996	0.000
T42.2 Succinimides and oxazolidinediones	0.004	0.996	0.000
T42.1 Iminostilbenes	0.004	0.996	0.000
B44.9 Aspergillosis, unspecified	0.004	0.996	0.000
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.004	0.996	0.000
D22.6 Melanocytic naevi of upper limb, including shoulder	0.004	0.996	0.000
D22.1 Melanocytic naevi of eyelid, including canthus	0.004	0.996	0.000
F33.9 Recurrent depressive disorder, unspecified	0.004	0.996	0.000
E23.0 Hypopituitarism	0.000	0.997	0.003
T43.0 Tricyclic and tetracyclic antidepressants	0.003	0.997	0.000
H54.7 Unspecified visual loss	0.003	0.997	0.000
N76.0 Acute vaginitis	0.000	0.997	0.003
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.003	0.997	0.000
T47.1 Other antacids and anti-gastric-secretion drugs	0.003	0.997	0.000
B44 Aspergillosis	0.003	0.997	0.000
T40.4 Other synthetic narcotics	0.003	0.997	0.000
C85.9 Non-Hodgkin's lymphoma, unspecified type	0.000	0.997	0.003
E27.4 Other and unspecified adrenocortical insufficiency	0.000	0.997	0.003
B44.1 Other pulmonary aspergillosis	0.003	0.997	0.000
M10.99 Gout, unspecified (Site unspecified)	0.003	0.997	0.000
F33 Recurrent depressive disorder	0.003	0.997	0.000
H11.0 Pterygium	0.000	0.997	0.003
B95.4 Other streptococcus as the cause of diseases classified to other chapters	0.003	0.997	0.000
E23.2 Diabetes insipidus	0.000	0.997	0.003
H54.0 Blindness, both eyes	0.003	0.997	0.000
F33.1 Recurrent depressive disorder, current episode moderate	0.003	0.997	0.000
T80.8 Other complications following infusion, transfusion and therapeutic injection	0.003	0.997	0.000
M88.90 Paget's disease of bone, unspecified (Multiple sites)	0.003	0.997	0.000
B44.8 Other forms of aspergillosis	0.002	0.997	0.000
B44.7 Disseminated aspergillosis	0.002	0.997	0.000
B44.2 Tonsillar aspergillosis	0.002	0.997	0.000
B44.0 Invasive pulmonary aspergillosis	0.002	0.997	0.000
T50.9 Other and unspecified drugs, medicaments and biological substances	0.002	0.997	0.000
F33.2 Recurrent depressive disorder, current episode severe without psychotic symptoms	0.002	0.997	0.000
B37.3 Candidiasis of vulva and vagina	0.002	0.998	0.000
G58 Other mononeuropathies	0.002	0.998	0.000
F33.0 Recurrent depressive disorder, current episode mild	0.002	0.998	0.000
E23 Hypofunction and other disorders of pituitary gland	0.000	0.998	0.002
H54 Blindness and low vision	0.002	0.998	0.000
F33.3 Recurrent depressive disorder, current episode severe with psychotic symptoms	0.002	0.998	0.000
F33.8 Other recurrent depressive disorders	0.002	0.998	0.000
F33.4 Recurrent depressive disorder, currently in remission	0.002	0.998	0.000
M43.16 Spondylolisthesis (Lumbar region)	0.002	0.998	0.000
F20.0 Paranoid schizophrenia	0.002	0.998	0.000
F25.9 Schizoaffective disorder, unspecified	0.002	0.998	0.000
F20 Schizophrenia	0.002	0.998	0.000
Z49.1 Extracorporeal dialysis	0.002	0.998	0.000
Z54.0 Convalescence following surgery	0.000	0.998	0.002
H11 Other disorders of conjunctiva	0.000	0.998	0.002
B37.8 Candidiasis of other sites	0.002	0.998	0.000
H11.8 Other specified disorders of conjunctiva	0.000	0.998	0.002
F25 Schizoaffective disorders	0.002	0.998	0.000
H11.3 Conjunctival haemorrhage	0.000	0.998	0.002
E04.9 Non-toxic goitre, unspecified	0.000	0.998	0.002
L73.9 Follicular disorder, unspecified	0.002	0.998	0.000
M88.9 Paget's disease of bone, unspecified	0.002	0.998	0.000
T80.2 Infections following infusion, transfusion and therapeutic injection	0.002	0.998	0.000
E27 Other disorders of adrenal gland	0.000	0.998	0.002
H54.6 Unqualified visual loss, one eye	0.002	0.998	0.000
F20.9 Schizophrenia, unspecified	0.002	0.998	0.000
I82.8 Embolism and thrombosis of other specified veins	0.002	0.998	0.000
H54.1 Blindness, one eye, low vision, other eye	0.002	0.998	0.000
J43.9 Emphysema, unspecified	0.002	0.998	0.000
E27.2 Addisonian crisis	0.000	0.998	0.002
B35-B49 Mycoses	0.002	0.998	0.000
C54.1 Endometrium	0.002	0.998	0.000
M88.99 Paget's disease of bone, unspecified (Site unspecified)	0.002	0.998	0.000
S42.30 Fracture of shaft of humerus (closed)	0.000	0.998	0.002
J40 Bronchitis, not specified as acute or chronic	0.002	0.998	0.000
F20-F29 Schizophrenia, schizotypal and delusional disorders	0.002	0.998	0.000
F25.1 Schizoaffective disorder, depressive type	0.002	0.998	0.000
G58.0 Intercostal neuropathy	0.002	0.998	0.000
E23.3 Hypothalamic dysfunction, not elsewhere classified	0.000	0.998	0.002
E23.1 Drug-induced hypopituitarism	0.000	0.998	0.002
H54.3 Unqualified visual loss, both eyes	0.002	0.998	0.000
H54.2 Low vision, both eyes	0.002	0.998	0.000
E27.1 Primary adrenocortical insufficiency	0.000	0.998	0.002
N32.0 Bladder-neck obstruction	0.000	0.998	0.002
B37 Candidiasis	0.002	0.998	0.000
G58.9 Mononeuropathy, unspecified	0.002	0.998	0.000
E23.7 Disorder of pituitary gland, unspecified	0.000	0.998	0.002
H11.1 Conjunctival degenerations and deposits	0.000	0.998	0.002
M88.95 Paget's disease of bone, unspecified (Pelvic region and thigh)	0.002	0.998	0.000
E27.8 Other specified disorders of adrenal gland	0.000	0.998	0.002
F20.8 Other schizophrenia	0.002	0.998	0.000
F20.6 Simple schizophrenia	0.002	0.998	0.000
F20.5 Residual schizophrenia	0.002	0.998	0.000
F20.4 Postschizophrenic depression	0.002	0.998	0.000
F20.3 Undifferentiated schizophrenia	0.002	0.998	0.000
F20.2 Catatonic schizophrenia	0.002	0.998	0.000
F20.1 Hebephrenic schizophrenia	0.002	0.998	0.000
H11.9 Disorder of conjunctiva, unspecified	0.000	0.998	0.002
H11.2 Conjunctival scars	0.000	0.998	0.002
H54.5 Low vision, one eye	0.002	0.998	0.000
M77.47 Metatarsalgia-Ankle/Foot	0.002	0.998	0.000
F25.8 Other schizoaffective disorders	0.002	0.998	0.000
F25.2 Schizoaffective disorder, mixed type	0.002	0.998	0.000
H54.4 Blindness, one eye	0.002	0.998	0.000
F25.0 Schizoaffective disorder, manic type	0.002	0.998	0.000
J44.0 Chronic obstructive pulmonary disease with acute lower respiratory infection	0.002	0.998	0.000
Z52.4 Kidney donor	0.002	0.998	0.000
M88.98 Paget's disease of bone, unspecified (Other)	0.002	0.998	0.000
M88.97 Paget's disease of bone, unspecified (Ankle and foot)	0.002	0.998	0.000
M88.96 Paget's disease of bone, unspecified (Lower leg)	0.002	0.998	0.000
M88.94 Paget's disease of bone, unspecified (Hand)	0.002	0.998	0.000
M88.93 Paget's disease of bone, unspecified (Forearm)	0.002	0.998	0.000
M88.92 Paget's disease of bone, unspecified (Upper arm)	0.002	0.998	0.000
M88.91 Paget's disease of bone, unspecified (Shoulder region)	0.002	0.998	0.000
E27.5 Adrenomedullary hyperfunction	0.000	0.998	0.002
E27.0 Other adrenocortical overactivity	0.000	0.998	0.002
G58.7 Mononeuritis multiplex	0.002	0.998	0.000
T80 Complications following infusion, transfusion and therapeutic injection	0.002	0.998	0.000
B95.3 Streptococcus pneumoniae as the cause of diseases classified to other chapters	0.002	0.998	0.000
Z85.7 Personal history of other malignant neoplasms of lymphoid, haematopoietic and related tissues	0.000	0.998	0.002
B49 Unspecified mycosis	0.002	0.998	0.000
F23 Acute and transient psychotic disorders	0.002	0.998	0.000
H57.9 Disorder of eye and adnexa, unspecified	0.000	0.998	0.002
F23.1 Acute polymorphic psychotic disorder with symptoms of schizophrenia	0.002	0.998	0.000
L43.9 Lichen planus, unspecified	0.000	0.998	0.002
F22 Persistent delusional disorders	0.002	0.998	0.000
M82.11 Osteoporosis in endocrine disorders (Shoulder region)	0.000	0.998	0.002
B48 Other mycoses, not elsewhere classified	0.002	0.998	0.000
B47 Mycetoma	0.002	0.998	0.000
B46 Zygomycosis	0.002	0.998	0.000
B45 Cryptococcosis	0.002	0.998	0.000
B43 Chromomycosis and phaeomycotic abscess	0.002	0.998	0.000
B42 Sporotrichosis	0.002	0.998	0.000
B41 Paracoccidioidomycosis	0.002	0.998	0.000
B40 Blastomycosis	0.002	0.998	0.000
B39 Histoplasmosis	0.002	0.998	0.000
B38 Coccidioidomycosis	0.002	0.998	0.000
B95 Streptococcus and staphylococcus as the cause of diseases classified to other chapters	0.002	0.998	0.000
E23.6 Other disorders of pituitary gland	0.000	0.998	0.002
B36 Other superficial mycoses	0.002	0.998	0.000
E27.3 Drug-induced adrenocortical insufficiency	0.000	0.998	0.002
F28 Other nonorganic psychotic disorders	0.002	0.998	0.000
F24 Induced delusional disorder	0.002	0.998	0.000
F21 Schizotypal disorder	0.002	0.998	0.000
D22.2 Melanocytic naevi of ear and external auricular canal	0.002	0.998	0.000
E27.9 Disorder of adrenal gland, unspecified	0.000	0.998	0.002
F52.2 Failure of genital response	0.002	0.998	0.000
N39.4 Other specified urinary incontinence	0.000	0.998	0.002
F99 Mental disorder, not otherwise specified	0.002	0.998	0.000
K83.8 Other specified diseases of biliary tract	0.002	0.998	0.000
Z96.8 Presence of other specified functional implants	0.002	0.998	0.000
M79.29 Neuralgia and neuritis, unspecified (Site unspecified)	0.000	0.998	0.002
B37.7 Candidal septicaemia	0.002	0.998	0.000
B37.6 Candidal endocarditis	0.002	0.998	0.000
B37.5 Candidal meningitis	0.002	0.998	0.000
I28.8 Other specified diseases of pulmonary vessels	0.002	0.998	0.000
K12.1 Other forms of stomatitis	0.000	0.998	0.002
D73.4 Cyst of spleen	0.002	0.998	0.000
H11.4 Other conjunctival vascular disorders and cysts	0.000	0.998	0.002
B35 Dermatophytosis	0.002	0.998	0.000
D89.2 Hypergammaglobulinaemia, unspecified	0.002	0.998	0.000
B37.2 Candidiasis of skin and nail	0.002	0.998	0.000
G31.8 Other specified degenerative diseases of nervous system	0.000	0.998	0.002
N76.8 Other specified inflammation of vagina and vulva	0.000	0.998	0.002
O43.8 Other placental disorders	0.002	0.998	0.000
M89.97 Disorder of bone, unspecified (Ankle and foot)	0.000	0.998	0.002
B37.1 Pulmonary candidiasis	0.002	0.998	0.000
B95.8 Unspecified staphylococcus as the cause of diseases classified to other chapters	0.002	0.998	0.000
B95.2 Streptococcus, group D, as the cause of diseases classified to other chapters	0.002	0.998	0.000
G60.0 Hereditary motor and sensory neuropathy	0.000	0.998	0.002
Z31.0 Tuboplasty or vasoplasty after previous sterilisation	0.000	0.998	0.002
C85 Other and unspecified types of non-Hodgkin's lymphoma	0.000	0.998	0.002
B37.4 Candidiasis of other urogenital sites	0.002	0.998	0.000
C22.0 Liver cell carcinoma	0.002	0.998	0.000
F22.0 Delusional disorder	0.002	0.998	0.000
I27.2 Other secondary pulmonary hypertension	0.002	0.998	0.000
T80.9 Unspecified complication following infusion, transfusion and therapeutic injection	0.001	0.998	0.000
T80.6 Other serum reactions	0.001	0.998	0.000
T80.5 Anaphylactic shock due to serum	0.001	0.998	0.000
T80.4 Rh incompatibility reaction	0.001	0.998	0.000
T80.3 ABO incompatibility reaction	0.001	0.998	0.000
T80.0 Air embolism following infusion, transfusion and therapeutic injection	0.001	0.998	0.000
F23.8 Other acute and transient psychotic disorders	0.001	0.998	0.000
F23.3 Other acute predominantly delusional psychotic disorders	0.001	0.998	0.000
F23.2 Acute schizophrenia-like psychotic disorder	0.001	0.998	0.000
D22 Melanocytic naevi	0.002	0.998	0.000
F22.9 Persistent delusional disorder, unspecified	0.001	0.998	0.000
F22.8 Other persistent delusional disorders	0.001	0.998	0.000
F60.7 Dependent personality disorder	0.002	0.998	0.000
B38.9 Coccidioidomycosis, unspecified	0.001	0.998	0.000
B38.8 Other forms of coccidioidomycosis	0.001	0.998	0.000
B38.7 Disseminated coccidioidomycosis	0.001	0.998	0.000
B38.4 Coccidioidomycosis meningitis	0.001	0.998	0.000
B38.3 Cutaneous coccidioidomycosis	0.001	0.998	0.000
B38.2 Pulmonary coccidioidomycosis, unspecified	0.001	0.998	0.000
B38.1 Chronic pulmonary coccidioidomycosis	0.001	0.998	0.000
B38.0 Acute pulmonary coccidioidomycosis	0.001	0.998	0.000
B39.9 Histoplasmosis, unspecified	0.001	0.998	0.000
B39.5 Histoplasmosis duboisii	0.001	0.998	0.000
B39.4 Histoplasmosis capsulati, unspecified	0.001	0.998	0.000
B39.3 Disseminated histoplasmosis capsulati	0.001	0.998	0.000
B39.2 Pulmonary histoplasmosis capsulati, unspecified	0.001	0.998	0.000
B39.1 Chronic pulmonary histoplasmosis capsulati	0.001	0.998	0.000
B39.0 Acute pulmonary histoplasmosis capsulati	0.001	0.998	0.000
B40.9 Blastomycosis, unspecified	0.001	0.998	0.000
B40.8 Other forms of blastomycosis	0.001	0.998	0.000
B40.7 Disseminated blastomycosis	0.001	0.998	0.000
B40.3 Cutaneous blastomycosis	0.001	0.998	0.000
B40.2 Pulmonary blastomycosis, unspecified	0.001	0.998	0.000
B40.1 Chronic pulmonary blastomycosis	0.001	0.998	0.000
B40.0 Acute pulmonary blastomycosis	0.001	0.998	0.000
B41.9 Paracoccidioidomycosis, unspecified	0.001	0.998	0.000
B41.8 Other forms of paracoccidioidomycosis	0.001	0.998	0.000
B41.7 Disseminated paracoccidioidomycosis	0.001	0.998	0.000
B41.0 Pulmonary paracoccidioidomycosis	0.001	0.998	0.000
B42.9 Sporotrichosis, unspecified	0.001	0.998	0.000
B42.8 Other forms of sporotrichosis	0.001	0.998	0.000
B42.7 Disseminated sporotrichosis	0.001	0.998	0.000
B42.1 Lymphocutaneous sporotrichosis	0.001	0.998	0.000
B42.0 Pulmonary sporotrichosis	0.001	0.998	0.000
B43.9 Chromomycosis, unspecified	0.001	0.998	0.000
B43.8 Other forms of chromomycosis	0.001	0.998	0.000
B43.2 Subcutaneous phaeomycotic abscess and cyst	0.001	0.998	0.000
B43.1 Phaeomycotic brain abscess	0.001	0.998	0.000
B43.0 Cutaneous chromomycosis	0.001	0.998	0.000
B45.9 Cryptococcosis, unspecified	0.001	0.998	0.000
B45.8 Other forms of cryptococcosis	0.001	0.998	0.000
B45.7 Disseminated cryptococcosis	0.001	0.998	0.000
B45.3 Osseous cryptococcosis	0.001	0.998	0.000
B45.2 Cutaneous cryptococcosis	0.001	0.998	0.000
B45.1 Cerebral cryptococcosis	0.001	0.998	0.000
B45.0 Pulmonary cryptococcosis	0.001	0.998	0.000
B46.9 Zygomycosis, unspecified	0.001	0.998	0.000
B46.8 Other zygomycoses	0.001	0.998	0.000
B46.5 Mucormycosis, unspecified	0.001	0.998	0.000
B46.4 Disseminated mucormycosis	0.001	0.998	0.000
B46.3 Cutaneous mucormycosis	0.001	0.998	0.000
B46.2 Gastro-intestinal mucormycosis	0.001	0.998	0.000
B46.1 Rhinocerebral mucormycosis	0.001	0.998	0.000
B46.0 Pulmonary mucormycosis	0.001	0.998	0.000
B47.9 Mycetoma, unspecified	0.001	0.998	0.000
B47.1 Actinomycetoma	0.001	0.998	0.000
B47.0 Eumycetoma	0.001	0.998	0.000
B48.8 Other specified mycoses	0.001	0.998	0.000
B48.7 Opportunistic mycoses	0.001	0.998	0.000
B48.4 Penicillosis	0.001	0.998	0.000
B48.3 Geotrichosis	0.001	0.998	0.000
B48.2 Allescheriasis	0.001	0.998	0.000
B48.1 Rhinosporidiosis	0.001	0.998	0.000
B48.0 Lobomycosis	0.001	0.998	0.000
C85.1 B-cell lymphoma, unspecified	0.000	0.998	0.002
F60.3 Emotionally unstable personality disorder	0.002	0.998	0.000
B36.8 Other specified superficial mycoses	0.001	0.998	0.000
B36.3 Black piedra	0.001	0.998	0.000
B36.2 White piedra	0.001	0.998	0.000
B36.1 Tinea nigra	0.001	0.998	0.000
B36.0 Pityriasis versicolor	0.001	0.998	0.000
F23.0 Acute polymorphic psychotic disorder without symptoms of schizophrenia	0.001	0.998	0.000
F45.8 Other somatoform disorders	0.002	0.998	0.000
F45.3 Somatoform autonomic dysfunction	0.002	0.998	0.000
R76.8 Other specified abnormal immunological findings in serum	0.002	0.998	0.000
F52 Sexual dysfunction, not caused by organic disorder or disease	0.001	0.998	0.000
F60 Specific personality disorders	0.002	0.998	0.000
M88.85 Paget's disease of other bones (Pelvic region and thigh)	0.001	0.998	0.000
B36.9 Superficial mycosis, unspecified	0.001	0.998	0.000
D73.5 Infarction of spleen	0.001	0.998	0.000
M16.7 Other secondary coxarthrosis	0.002	0.998	0.000
S62.50 Fracture of thumb (closed)	0.000	0.998	0.002
D73.1 Hypersplenism	0.001	0.998	0.000
F34.1 Dysthymia	0.001	0.998	0.000
F45.9 Somatoform disorder, unspecified	0.001	0.998	0.000
K59.8 Other specified functional intestinal disorders	0.000	0.998	0.002
T80.1 Vascular complications following infusion, transfusion and therapeutic injection	0.001	0.998	0.000
D73.3 Abscess of spleen	0.001	0.998	0.000
D73 Diseases of spleen	0.002	0.998	0.000
S72.10 Pertrochanteric fracture (closed)	0.000	0.998	0.001
B35.9 Dermatophytosis, unspecified	0.001	0.998	0.000
B35.8 Other dermatophytoses	0.001	0.998	0.000
B35.6 Tinea cruris	0.001	0.998	0.000
B35.5 Tinea imbricata	0.001	0.998	0.000
B35.4 Tinea corporis	0.001	0.998	0.000
B35.2 Tinea manuum	0.001	0.998	0.000
B35.0 Tinea barbae and tinea capitis	0.001	0.998	0.000
K38.1 Appendicular concretions	0.001	0.998	0.000
M88.8 Paget's disease of other bones	0.001	0.998	0.000
N76 Other inflammation of vagina and vulva	0.000	0.998	0.001
D73.8 Other diseases of spleen	0.001	0.999	0.000
F23.9 Acute and transient psychotic disorder, unspecified	0.001	0.999	0.000
H72.8 Other perforations of tympanic membrane	0.000	0.999	0.001
L94.0 Localised scleroderma [morphea]	0.001	0.999	0.000
T82.8 Other complications of cardiac and vascular prosthetic devices, implants and grafts	0.001	0.999	0.000
Z89.6 Acquired absence of leg above knee	0.000	0.999	0.001
F29 Unspecified nonorganic psychosis	0.001	0.999	0.000
F45 Somatoform disorders	0.001	0.999	0.000
D48.1 Connective and other soft tissue	0.000	0.999	0.001
L30.8 Other specified dermatitis	0.001	0.999	0.000
M88 Paget's disease of bone [osteitis deformans]	0.001	0.999	0.000
C85.2 Mediastinal (thymic) large B-cell lymphoma	0.000	0.999	0.001
C85.0 Lymphosarcoma	0.000	0.999	0.001
F30.0 Hypomania	0.001	0.999	0.000
F51.0 Nonorganic insomnia	0.001	0.999	0.000
U89.8 Agent resistant to other single specified antibiotic	0.000	0.999	0.001
F30 Manic episode	0.001	0.999	0.000
F99-F99 Unspecified mental disorder	0.001	0.999	0.000
B97.8 Other viral agents as the cause of diseases classified to other chapters	0.001	0.999	0.000
D22.9 Melanocytic naevi, unspecified	0.001	0.999	0.000
N76.5 Ulceration of vagina	0.000	0.999	0.001
R50.0 Fever with chills	0.001	0.999	0.000
F34 Persistent mood [affective] disorders	0.001	0.999	0.000
M43.19 Spondylolisthesis (Site unspecified)	0.001	0.999	0.000
B35.1 Tinea unguium	0.001	0.999	0.000
F45.2 Hypochondriacal disorder	0.001	0.999	0.000
H54.9 Unspecified visual impairment (binocular)	0.001	0.999	0.000
M43.1 Spondylolisthesis	0.001	0.999	0.000
N76.2 Acute vulvitis	0.000	0.999	0.001
C54 Malignant neoplasm of corpus uteri	0.001	0.999	0.000
F51 Nonorganic sleep disorders	0.001	0.999	0.000
B35.3 Tinea pedis	0.001	0.999	0.000
F60.8 Other specific personality disorders	0.001	0.999	0.000
F60.5 Anankastic personality disorder	0.001	0.999	0.000
F60.4 Histrionic personality disorder	0.001	0.999	0.000
F60.2 Dissocial personality disorder	0.001	0.999	0.000
F60.1 Schizoid personality disorder	0.001	0.999	0.000
F60.0 Paranoid personality disorder	0.001	0.999	0.000
N76.3 Subacute and chronic vulvitis	0.000	0.999	0.001
F30.2 Mania with psychotic symptoms	0.001	0.999	0.000
F52.9 Unspecified sexual dysfunction, not caused by organic disorder or disease	0.001	0.999	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations